Detalhe da pesquisa
1.
Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia.
Blood Adv
; 4(17): 4136-4146, 2020 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886753
2.
Effect of darapladib treatment on endarterectomy carotid plaque lipoprotein-associated phospholipase A2 activity: a randomized, controlled trial.
PLoS One
; 9(2): e89034, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24586490
3.
Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia.
Am J Med
; 127(1): 36-44.e1, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24384100
4.
Prevalence of severe (500 to 2,000 mg/dl) hypertriglyceridemia in United States adults.
Am J Cardiol
; 107(6): 891-7, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21247544
5.
Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients.
Curr Med Res Opin
; 26(4): 907-15, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20156032